The worldwide trend of using botanical drugs and strategies for developing global drugs

Cited 140 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorKyung Seop Ahn-
dc.date.accessioned2017-08-29-
dc.date.available2017-08-29-
dc.date.issued2017-
dc.identifier.issn1225-8687-
dc.identifier.uri10.5483/BMBRep.2017.50.3.221ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/17086-
dc.description.abstractNatural product drugs, or botanical drugs, are drugs composed of natural substances which have constituents with healthenhancing or medicinal activities. In Korea, government-led projects brought attention to botanical drugs invigorating domestic botanical drug industry. Foreign markets, as well, are growing bigger as the significance of botanical drugs stood out. To follow along with the tendency, Korea puts a lot of effort on developing botanical drugs suitable for global market. However, standards for approving drug sales vary by countries. And also, thorough standardization, certification, clinical studies and data of these will be required as well as data confirming safety and effectiveness. Meanwhile, as an international exchange in botanical drug market continues, the importance of plant resources was emphasized. Thus countries' ownership of domestic natural resources became vital. Not only establishing a systematic method to secure domestic plant resources, but also cooperation with other countries on sharing natural resources is essential to procure natural resources effectively. Korea started to show visible results with botanical drugs, and asthma/COPD treatment made out of speedwell is one example. Sufficient investment and government's active support for basic infrastructure for global botanical drugs will bring Korea to much higher level of botanical drug development-
dc.publisherKorea Soc-Assoc-Inst-
dc.titleThe worldwide trend of using botanical drugs and strategies for developing global drugs-
dc.title.alternativeThe worldwide trend of using botanical drugs and strategies for developing global drugs-
dc.typeArticle-
dc.citation.titleBMB Reports-
dc.citation.number3-
dc.citation.endPage116-
dc.citation.startPage111-
dc.citation.volume50-
dc.contributor.affiliatedAuthorKyung Seop Ahn-
dc.contributor.alternativeName안경섭-
dc.identifier.bibliographicCitationBMB Reports, vol. 50, no. 3, pp. 111-116-
dc.identifier.doi10.5483/BMBRep.2017.50.3.221-
dc.subject.keywordBotanical drug-
dc.subject.keywordIND-
dc.subject.keywordNatural product-
dc.subject.keywordPlant extract bank-
dc.subject.keywordReverse pharmacology-
dc.subject.localBotanical drug-
dc.subject.localbotanical drug-
dc.subject.localIND-
dc.subject.localnatural products-
dc.subject.localNatural Product-
dc.subject.localNatural products-
dc.subject.localnatural product-
dc.subject.localNatural product-
dc.subject.localplant extract bank-
dc.subject.localPlant extract bank-
dc.subject.localReverse pharmacology-
dc.description.journalClassY-
Appears in Collections:
Ochang Branch Institute > Natural Product Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.